SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (1052)12/21/1998 8:16:00 PM
From: Henry Niman  Respond to of 1722
 
Tomorrow's Circulation will have a review on the benefits of CP IIb/IIIa inhibitors like CNTO's Reopro, CORR's Integrelin, and MRK's Aggrastat on reducing death rate in heart attack patients. Details linked to Cardiovascular Section of New Therapeutics page at biocognizance.com